Archives for December 5, 2006

← 2006

Biolex technology produces superior MAbs

By  Anna Lewcock

A new cell culture process developed by Biolex Pharmaceuticals produces monoclonal antibodies which are both more potent and more effective.

CROs - where is the money being spent?

By  Kirsty Barnes

The contract research organisation (CRO) industry is in full swing as the clinical trial outsourcing trend continues, but where is the money being spent?

Lonza and BioOne continue investing in Singapore

By  Emilie Reymond

Swiss custom manufacturer Lonza and Singapore's BioOne Capital have announced a new joint venture to build a $350m (€263m) large-scale manufacturing facility in Singapore.

AAIPharma to offer 'one-stop shop' for drug development

By  Emilie Reymond

AAIPharma has announced it has signed a contract manufacturing agreement with Mallinckrodt Pharmaceuticals Outsourcing which aims to provide a "one-stop drug development solution" for drug makers.